Suggestions
Steve Schwartz
CTO, co-founder at CircNova, Inc., Owner at Alfa Jango
Steve Schwartz is a versatile professional with a background in Mechanical and Electrical Engineering, known for his roles as a founder, CTO, and open-source software author.
Currently serving as the CTO and co-founder of CircNova, Steve is spearheading the development of NovaEngine AI, focusing on circular RNA-based therapies for challenging cancers and diseases.
Previously, Steve co-founded Genomenon, a company that grew to approximately 150 employees and specialized in genome interpretation software utilizing AI for cancer diagnosis and treatment, as well as precision medicine development. The company raised over $30 million in funding and acquired Boston Genetics in 2023.
Aside from his entrepreneurial ventures, Steve has a strong background in engineering, software development, and open-source software, with a significant impact in the industry with software boasting hundreds of millions of downloads.
An alumnus of Kettering University, Steve has a background in both Mechanical and Electrical Engineering, which has undoubtedly influenced his innovative approach to technology and startups.
Steve actively invests in startups, offers strategic guidance to founders, and is a sought-after speaker on technical startups, software development, and Artificial Intelligence.
His professional journey includes diverse roles such as technical advisor, managing member, back- and front-end development, and marketing engineer in various organizations, showcasing his wide-ranging expertise and experience.
From his early days as a Mechanical / Electrical Engineering Intern at Bosch to founding and leading multiple successful ventures, Steve Schwartz's career exemplifies a dedication to innovation, entrepreneurship, and technological advancement.
Highlights
Was I right with my AI startup hot take? New study indicates describing products as AI reduces trust and purchase intentions.
https://lnkd.in/etzte9WB
I've gotten so much push-back over the years when saying startups are too quick to describe their products as AI in industries where the target customer considers it undesirable. I think it's done for ego and to impress investors. Examples I've seen include products in clinical diagnosis and financial accounting. Some needs require utmost predictability, observability, and ultimately, understandability.
There are some industries and markets that benefit from AI. But that's the point. Think first. Market the benefits. I've seen some claim AI isn't a benefit, it's a feature. I'd argue it's not even a feature, it's an implementation detail, like using an object-oriented programming language or a relational database. It can imply some feature or benefit, but why not instead market the benefit directly?
Focus on the needs of the customer and industry. Describe the benefits. For customers and investors alike, remove the AI veil of opacity, by describing simply what the AI is doing.
AI startup hot take: If a startup is putting AI in their name or domain, they're more focused on the tech and hype of AI than the problem they're solving.*
When the scope of the company's technology grows beyond the AI components, and the AI hype dips, they'll be saddled with an identity focused on a single aspect of the company. I may start calling this nominative hype'rfocus, describing a company's name being both hyperfocused [on one small aspect], as well as being focused on hype. I'd be concerned the nominative hype'rfocus is indicative of a broader, myopic hype'rfocus in the company's strategy and business.
I'm also weary of using a .ai top-level domain, intended for use by another country and controlled by their government, and thus subject to changes in their commerce and politics. Heed lessons from the .ly domain. Are the incremental branding benefits of the .ai TLD worth the risks?
*If the problem the company is solving is to help others implement AI, then ignore this post.
